EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samples

Kai Song, Emon Elboudwarej iD, Xi Zhao iD, Luting Zhuo, David Pan, Jinfeng Liu, Carrie Brachmann, Scott D Patterson, Oh Kyu Yoon, Marianna Zavodovskaya iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0293400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Kai Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gilead Sciences, Inc., Foster City, California, United States of America. Hauptthemen laut MEDLINE: Gene Expression Profiling, RNA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical tumor tissues that are preserved as formalin-fixed paraffin-embedded (FFPE) samples result in extensive cross-linking, fragmentation, and chemical modification of RNA, posing significant challenges for RNA-seq-based gene expression profiling. This study sought to define an optimal RNA-seq protocol for FFPE samples. We employed a common RNA extraction method and then compared RNA-seq library preparation protocols including RNAaccess, RiboZero and PolyA in terms of sequencing quality and concordance of gene expression using FFPE and case-matched fresh-frozen (FF) triple-negative breast cancer (TNBC) tissues. We found that RNAaccess, a method based on exome capture, produced the most concordant results. Applying RNAaccess to FFPE gastric cancer tissues, we established a minimum RNA DV200 requirement of 10% and a RNA input amount of 10ng that generated highly reproducible gene expression data. Lastly, we demonstrated that RNAaccess and NanoString platforms produced highly concordant expression profiles from FFPE samples for shared genes; however, RNA-seq may be preferred for clinical biomarker discovery work because of the broader coverage of the transcriptome. Taken together, these results support the selection of RNA-seq RNAaccess method for gene expression profiling of FFPE samples. The minimum requirements for RNA quality and input established here may allow for inclusion of clinical FFPE samples of sub-optimal quality in gene expression analyses and ultimately increasing the statistical power of such analyses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene Expression ProfilingRNARNA-SeqTissue FixationSequence Analysis, RNAParaffin EmbeddingFormaldehyde

Substanzen

RNAFormaldehyde

Autor:innen und Institutionen

  • Gilead Sciences, Inc., Foster City, California, United States of America.

ORCID-Profile: Emon Elboudwarej, Xi Zhao, Marianna Zavodovskaya

Förderung

  • Gilead Sciences

Zitieren

APA

Song, K., Elboudwarej, E., Zhao, X., Zhuo, L., Pan, D., Liu, J., Brachmann, C., Patterson, S. D., Yoon, O. K., & Zavodovskaya, M. (2023). RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samples. PLOS ONE. https://doi.org/10.1371/journal.pone.0293400

Vancouver

Song K, Elboudwarej E, Zhao X, Zhuo L, Pan D, Liu J, et al. RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samples. PLOS ONE. 2023. doi:10.1371/journal.pone.0293400

BibTeX
@article{Song2023,
  author = {Song, Kai and Elboudwarej, Emon and Zhao, Xi and Zhuo, Luting and Pan, David and Liu, Jinfeng and Brachmann, Carrie and Patterson, Scott D and Yoon, Oh Kyu and Zavodovskaya, Marianna},
  title = {RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samples},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0293400}
}
Kostenlos starten →